申请人:——
公开号:US20040229890A1
公开(公告)日:2004-11-18
This invention relates to diaminopyrroloquinazoline compounds which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
这项发明涉及二氨基吡咯喹唑啉化合物,这些化合物对抑制蛋白酪氨酸磷酸酶特别是PTP1B具有用处,并且对降低哺乳动物的血糖浓度有用。